587 related articles for article (PubMed ID: 8524212)
21. Induction of apoptosis without differentiation by retinoic acid in PLB-985 cells requires the activation of both RAR and RXR.
Monczak Y; Trudel M; Lamph WW; Miller WH
Blood; 1997 Nov; 90(9):3345-55. PubMed ID: 9345016
[TBL] [Abstract][Full Text] [Related]
22. Suprabasal expression of a dominant-negative RXR alpha mutant in transgenic mouse epidermis impairs regulation of gene transcription and basal keratinocyte proliferation by RAR-selective retinoids.
Feng X; Peng ZH; Di W; Li XY; Rochette-Egly C; Chambon P; Voorhees JJ; Xiao JH
Genes Dev; 1997 Jan; 11(1):59-71. PubMed ID: 9000050
[TBL] [Abstract][Full Text] [Related]
23. Physiological and retinoid-induced proliferations of epidermis basal keratinocytes are differently controlled.
Chapellier B; Mark M; Messaddeq N; Calléja C; Warot X; Brocard J; Gérard C; Li M; Metzger D; Ghyselinck NB; Chambon P
EMBO J; 2002 Jul; 21(13):3402-13. PubMed ID: 12093741
[TBL] [Abstract][Full Text] [Related]
24. Analysis of the factors involved in the retinoic acid-induced differentiation of a retinoid-hypersensitive embryonal carcinoma cell mutant.
Dietrich JM; McCormick PJ
Exp Cell Res; 1994 Feb; 210(2):201-8. PubMed ID: 8299717
[TBL] [Abstract][Full Text] [Related]
25. Dominant negative retinoid X receptor beta inhibits retinoic acid-responsive gene regulation in embryonal carcinoma cells.
Minucci S; Zand DJ; Dey A; Marks MS; Nagata T; Grippo JF; Ozato K
Mol Cell Biol; 1994 Jan; 14(1):360-72. PubMed ID: 8264603
[TBL] [Abstract][Full Text] [Related]
26. Retinoic acid receptor- and retinoid X receptor-selective retinoids activate signaling pathways that converge on AP-1 and inhibit squamous differentiation in human bronchial epithelial cells.
Lee HY; Dawson MI; Walsh GL; Nesbitt JC; Eckert RL; Fuchs E; Hong WK; Lotan R; Kurie JM
Cell Growth Differ; 1996 Aug; 7(8):997-1004. PubMed ID: 8853895
[TBL] [Abstract][Full Text] [Related]
27. Retinoid X receptor (RXR) agonist-induced activation of dominant-negative RXR-retinoic acid receptor alpha403 heterodimers is developmentally regulated during myeloid differentiation.
Johnson BS; Chandraratna RA; Heyman RA; Allegretto EA; Mueller L; Collins SJ
Mol Cell Biol; 1999 May; 19(5):3372-82. PubMed ID: 10207061
[TBL] [Abstract][Full Text] [Related]
28. Retinoid X receptor (RXR) within the RXR-retinoic acid receptor heterodimer binds its ligand and enhances retinoid-dependent gene expression.
Minucci S; Leid M; Toyama R; Saint-Jeannet JP; Peterson VJ; Horn V; Ishmael JE; Bhattacharyya N; Dey A; Dawid IB; Ozato K
Mol Cell Biol; 1997 Feb; 17(2):644-55. PubMed ID: 9001218
[TBL] [Abstract][Full Text] [Related]
29. A histone deacetylase inhibitor potentiates retinoid receptor action in embryonal carcinoma cells.
Minucci S; Horn V; Bhattacharyya N; Russanova V; Ogryzko VV; Gabriele L; Howard BH; Ozato K
Proc Natl Acad Sci U S A; 1997 Oct; 94(21):11295-300. PubMed ID: 9326603
[TBL] [Abstract][Full Text] [Related]
30. Greater synergism of retinoic acid receptor (RAR) agonists with vitamin D3 than that of retinoid X receptor (RXR) agonists with regard to growth inhibition and differentiation induction in monoblastic leukemia cells.
Makishima M; Shudo K; Honma Y
Biochem Pharmacol; 1999 Mar; 57(5):521-9. PubMed ID: 9952315
[TBL] [Abstract][Full Text] [Related]
31. [Genetic control of the development by retinoic acid].
Mark M; Kastner P; Ghyselinck NB; Krezel W; Dupé V; Chambon P
C R Seances Soc Biol Fil; 1997; 191(1):77-90. PubMed ID: 9181129
[TBL] [Abstract][Full Text] [Related]
32. Evidence that retinoid X receptors mediate retinoid-dependent transcriptional activation of the retinoic acid receptor beta gene in S91 melanoma cells.
Spanjaard RA; Sugawara A; Ikeda M; Chin WW
J Biol Chem; 1995 Jul; 270(29):17429-36. PubMed ID: 7615548
[TBL] [Abstract][Full Text] [Related]
33. Genomic footprinting of retinoic acid regulated promoters in embryonal carcinoma cells.
Dey A; Ozato K
Methods; 1997 Feb; 11(2):197-204. PubMed ID: 8993032
[TBL] [Abstract][Full Text] [Related]
34. Retinoids increase human apolipoprotein A-11 expression through activation of the retinoid X receptor but not the retinoic acid receptor.
Vu-Dac N; Schoonjans K; Kosykh V; Dallongeville J; Heyman RA; Staels B; Auwerx J
Mol Cell Biol; 1996 Jul; 16(7):3350-60. PubMed ID: 8668150
[TBL] [Abstract][Full Text] [Related]
35. Critical role of both retinoid nuclear receptors and retinoid-X-receptors in mediating growth inhibition of ovarian cancer cells by all-trans retinoic acid.
Wu S; Zhang D; Zhang ZP; Soprano DR; Soprano KJ
Oncogene; 1998 Dec; 17(22):2839-49. PubMed ID: 9879990
[TBL] [Abstract][Full Text] [Related]
36. Retinoic acid receptor and retinoid X receptor expression in retinoic acid-resistant human tumor cell lines.
van der Leede BM; van den Brink CE; van der Saag PT
Mol Carcinog; 1993; 8(2):112-22. PubMed ID: 7691069
[TBL] [Abstract][Full Text] [Related]
37. Ligand-dependent activation of transcription in vitro by retinoic acid receptor alpha/retinoid X receptor alpha heterodimers that mimics transactivation by retinoids in vivo.
Dilworth FJ; Fromental-Ramain C; Remboutsika E; Benecke A; Chambon P
Proc Natl Acad Sci U S A; 1999 Mar; 96(5):1995-2000. PubMed ID: 10051583
[TBL] [Abstract][Full Text] [Related]
38. Targeted disruption of retinoic acid receptor alpha (RAR alpha) and RAR gamma results in receptor-specific alterations in retinoic acid-mediated differentiation and retinoic acid metabolism.
Boylan JF; Lufkin T; Achkar CC; Taneja R; Chambon P; Gudas LJ
Mol Cell Biol; 1995 Feb; 15(2):843-51. PubMed ID: 7823950
[TBL] [Abstract][Full Text] [Related]
39. Conformationally defined 6-s-trans-retinoic acid analogs. 3. Structure-activity relationships for nuclear receptor binding, transcriptional activity, and cancer chemopreventive activity.
Muccio DD; Brouillette WJ; Alam M; Vaezi MF; Sani BP; Venepally P; Reddy L; Li E; Norris AW; Simpson-Herren L; Hill DL
J Med Chem; 1996 Sep; 39(19):3625-35. PubMed ID: 8809153
[TBL] [Abstract][Full Text] [Related]
40. A pleiotropic response is induced in F9 embryonal carcinoma cells and rhino mouse skin by All-trans-retinoic acid, a RAR agonist but not by SR11237, a RXR-selective agonist.
Gendimenico GJ; Stim TB; Corbo M; Janssen B; Mezick JA
J Invest Dermatol; 1994 May; 102(5):676-80. PubMed ID: 8176247
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
